use of regorafenib in refractory mcrc
Published 9 years ago • 390 plays • Length 7:35Download video MP4
Download video MP3
Similar videos
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
4:14
the use of regorafenib in clinical practice
-
4:26
sequencing of therapy in refractory mcrc
-
8:14
optimizing treatment with regorafenib in metastic colorectal cancer
-
7:32
treatment options in refractory mcrc
-
3:04
treatment goals in refractory mcrc
-
2:13
later-line treatment for mcrc: regorafenib or tas-102?
-
7:46
clinical use of regorafenib in mhcc
-
5:31
practical advice for using regorafenib
-
1:21
dr. bekaii-saab discusses regorafenib use in mcrc
-
3:10
regorafenib in refractory biliary tract cancer
-
1:16
dr. bekaii-saab on tas-102 and regorafenib in mcrc
-
11:24
managing toxicities associated with regorafenib
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc
-
1:35
dr. lockhart on next steps for regorafenib and tas-102 in mcrc
-
10:02
role of the multikinase inhibitor regorafenib in metastatic colorectal cancer
-
1:36
optimal dosing of regorafenib in colorectal cancer
-
1:39
dr. van cutsem discusses regorafenib for the treatment of patients with chemorefractory mcrc
-
4:53
debate: salvage therapy for mcrc? - tas-102 followed by regorafenib